The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer. [electronic resource]
Producer: 20190423Description: 1719-1728 p. digitalISSN:- 1791-7530
- Aldehyde Dehydrogenase -- genetics
- Aldehyde Dehydrogenase 1 Family
- Animals
- Antineoplastic Agents -- pharmacology
- Basic Helix-Loop-Helix Transcription Factors -- metabolism
- Caco-2 Cells
- Colonic Neoplasms -- drug therapy
- Cyclooxygenase 2 -- metabolism
- Dinoprostone -- metabolism
- Doublecortin-Like Kinases
- Female
- HT29 Cells
- Humans
- Hydroxyprostaglandin Dehydrogenases -- metabolism
- Intracellular Signaling Peptides and Proteins -- genetics
- Mice, Inbred BALB C
- Mice, Nude
- Neoplastic Stem Cells -- drug effects
- Oligopeptides -- pharmacology
- Protein Serine-Threonine Kinases -- genetics
- Retinal Dehydrogenase
- Tumor Burden -- drug effects
- Tumor Microenvironment
- Wnt Signaling Pathway -- drug effects
- Wnt-5a Protein -- agonists
- Xenograft Model Antitumor Assays
- beta Catenin -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.